Apolipoprotein changes associated with the plasma lipid-regulating activity of gemfibrozil in cholesterol-fed rats.
Gemfibrozil (Lopid) is a new plasma lipid-regulating drug that decreases very low and low density lipoprotein (VLD/LDL) and increases high density lipoprotein (HDL) concentrations in man. The present experiments tested the effects of gemfibrozil on plasma lipoproteins and apolipoproteins in rats fed...
Main Authors: | B R Krause, R S Newton |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
1985-08-01
|
Series: | Journal of Lipid Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520342966 |
Similar Items
-
Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine
by: Yoh Umeda, et al.
Published: (2001-08-01) -
Gemfibrozil significantly lowers cynomolgus monkey plasma lipoprotein[a]-protein and liver apolipoprotein[a] mRNA levels.
by: R. Ramharack, et al.
Published: (1995-06-01) -
The Synthesis of Gemfibrozil
by: Owe Yang Dah-Chung, et al.
Published: (1994) -
Gemfibrozil-Induced Polyuria
by: Ashraf Ahmed, et al.
Published: (2021-04-01) -
Independent effects of dietary saturated fat and cholesterol on plasma lipids, lipoproteins, and apolipoprotein E.
by: E A Fisher, et al.
Published: (1983-08-01)